Clinical investigation of medicinal products in the treatment of patients with acute respiratory distress syndrome

  • Email
  • Help
Current effective version

Revision 1 - Adopted guideline

Reference numberCPMP/EWP/504/97 Rev. 1
Published21/09/2006
Effective from01/04/2007
KeywordsAcute respiratory distress syndrome (ARDS)
DescriptionThis document provides guidance for the evaluation of new medicinal products for prevention and treatment of acute respiratory distress syndrome.


Document history

Revision 1

Current version

Adopted guideline


Overview of comments

In operation: 01/04/2007–present


Published: 21/09/2006


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more